share_log

Olema Pharmaceuticals Q4 EPS $(0.49) Misses $(0.48) Estimate

Moomoo 24/7 ·  Mar 11 16:04

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 24.62 percent increase over losses of $(0.65) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment